Maciej Banach

187.2k total citations · 7 hit papers
987 papers, 28.9k citations indexed

About

Maciej Banach is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Maciej Banach has authored 987 papers receiving a total of 28.9k indexed citations (citations by other indexed papers that have themselves been cited), including 389 papers in Surgery, 304 papers in Cardiology and Cardiovascular Medicine and 173 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Maciej Banach's work include Lipoproteins and Cardiovascular Health (328 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (114 papers) and Cancer, Lipids, and Metabolism (94 papers). Maciej Banach is often cited by papers focused on Lipoproteins and Cardiovascular Health (328 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (114 papers) and Cancer, Lipids, and Metabolism (94 papers). Maciej Banach collaborates with scholars based in Poland, United States and United Kingdom. Maciej Banach's co-authors include Amirhossein Sahebkar, Jacek Rysz, Dimitri P. Mikhailidis, Peter P. Tóth, Maria-Corina Șerban, Mohsen Mazidi, Peter E. Penson, Niki Katsiki, Matteo Pirro and Manfredi Rizzo and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Maciej Banach

930 papers receiving 28.3k citations

Hit Papers

Efficacy and Safety of Be... 2018 2026 2020 2023 2019 2018 2021 2020 2022 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
    2019 301 citations Maciej Banach et al. profile →
  2. Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study
    2018 294 citations Maciej Banach et al. profile →
  3. Quercetin and metabolic syndrome: A review
    2021 276 citations Maciej Banach et al. profile →
  4. Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways
    2020 256 citations Maciej Banach, Amirhossein Sahebkar et al. profile →
  5. Prevalence of statin intolerance: a meta-analysis
    2022 255 citations Dimitri P. Mikhailidis, Amirhossein Sahebkar et al. European Heart Journal profile →
  6. Effects of statins on mitochondrial pathways
    2021 167 citations Maciej Banach, Tannaz Jamialahmadi et al. profile →
  7. The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis
    2023 90 citations Maciej Banach, Joanna Lewek et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Maciej Banach 10.0k 7.0k 5.1k 4.5k 3.4k 987 28.9k
Erik S.G. Stroes 13.9k 1.4× 8.2k 1.2× 6.8k 1.3× 5.1k 1.1× 3.2k 1.0× 496 29.5k
Winfried März 7.2k 0.7× 4.8k 0.7× 5.6k 1.1× 4.0k 0.9× 2.7k 0.8× 662 24.3k
Alberico L. Catapano 14.8k 1.5× 7.3k 1.0× 8.4k 1.7× 5.1k 1.1× 3.7k 1.1× 656 30.1k
Robert A. Hegele 10.3k 1.0× 8.1k 1.2× 7.8k 1.5× 7.7k 1.7× 2.9k 0.9× 731 26.8k
Chris J. Packard 8.1k 0.8× 4.8k 0.7× 7.4k 1.5× 2.5k 0.6× 4.2k 1.3× 209 19.1k
Ulrich Laufs 10.6k 1.1× 9.6k 1.4× 3.7k 0.7× 7.3k 1.6× 2.9k 0.8× 507 28.3k
Michael H. Davidson 12.9k 1.3× 4.5k 0.6× 8.4k 1.7× 2.9k 0.6× 2.2k 0.7× 420 23.1k
Ulf Landmesser 10.8k 1.1× 15.2k 2.2× 4.4k 0.9× 7.0k 1.5× 2.6k 0.8× 574 34.0k
Robert H. Eckel 9.5k 1.0× 8.6k 1.2× 7.1k 1.4× 3.4k 0.8× 3.5k 1.0× 168 28.4k
Henry N. Ginsberg 11.1k 1.1× 6.9k 1.0× 11.4k 2.3× 6.5k 1.4× 5.0k 1.5× 325 27.9k

Countries citing papers authored by Maciej Banach

Since Specialization
Citations

This map shows the geographic impact of Maciej Banach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maciej Banach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maciej Banach more than expected).

Fields of papers citing papers by Maciej Banach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maciej Banach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maciej Banach. The network helps show where Maciej Banach may publish in the future.

Co-authorship network of co-authors of Maciej Banach

This figure shows the co-authorship network connecting the top 25 collaborators of Maciej Banach. A scholar is included among the top collaborators of Maciej Banach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maciej Banach. Maciej Banach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zadeh, Seyed Saeed Tamehri, et al.. (2025). ANGPTL3 vital role in different kidney diseases. Current knowledge and future perspectives. Biomedicine & Pharmacotherapy. 188. 118189–118189.
2.
Lewek, Joanna, Agata Bielecka‐Dąbrowa, Peter P. Tóth, & Maciej Banach. (2024). Dyslipidaemia management in pregnant patients: a 2024 update. European Heart Journal Open. 4(3). oeae032–oeae032. 20 indexed citations
3.
Banach, Maciej, Stanisław Surma, Grzegorz Dzida, et al.. (2024). The Prevention Opportunities of Retinopathy in Diabetic Patients - the Position Paper endorsed by the Polish Lipid Association.. Archives of Medical Science. 20(6). 1754–1769.
4.
Myśliwiec, Małgorzata, Mieczysław Walczak, Jarosław Peregud‐Pogorzelski, et al.. (2024). 2024 Polish Recommendations for the Management of Familial Hypercholesterolemia in Children and Adolescents.. Archives of Medical Science. 20(6). 1741–1753. 1 indexed citations
5.
Miszalski‐Jamka, Karol, et al.. (2024). AI-based algorithm for assessing coronary artery calcium score on contrast-enhanced cardiac computed tomography scans. European Heart Journal. 45(Supplement_1). 1 indexed citations
6.
7.
Chen, Yang, Ying X. Gue, Maciej Banach, et al.. (2024). Phenotypes of Polish primary care patients using hierarchical clustering: Exploring the risk of mortality in the LIPIDOGEN2015 study cohort. European Journal of Clinical Investigation. 54(10). e14261–e14261. 3 indexed citations
8.
Gąsecka, Aleksandra, et al.. (2024). Lipoprotein (a) measurement: potential for personalized cardiovascular disease management in a patient with acute myocardial infarction. Archives of Medical Science. 20(3). 1043–1047. 1 indexed citations
9.
Sosnowska, Bożena, Joanna Lewek, Agata Bielecka‐Dąbrowa, et al.. (2024). The prevalence, patients' characteristics, and hyper-Lp(a)-emia risk factors in the Polish population. The first results from the PMMHRI-Lp(a) Registry. Progress in Cardiovascular Diseases. 86. 54–61. 8 indexed citations
10.
Chen, Meijie, et al.. (2024). Aclysiran, an RNAi therapeutic agent targeting ACLY, treats hypercholesterolemia and atherosclerosis in ApoE–/– mice. Acta Pharmaceutica Sinica B. 14(12). 5505–5508. 1 indexed citations
11.
Katsiki, Niki, Michal Vráblík, Maciej Banach, & Ioanna Gouni‐Berthold. (2023). Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a). Pharmaceuticals. 16(4). 577–577. 35 indexed citations
12.
Surma, Stanisław, et al.. (2023). Eliminating atherosclerotic cardiovascular disease residual risk. European Heart Journal. 44(45). 4731–4733. 18 indexed citations
13.
Gumpricht, Eric, et al.. (2023). The Effect Of Curcumin On Hypoxia In Tumor Microenvironment As a Regulatory Factor In Cancer. Archives of Medical Science. 19(6). 1616–1629. 7 indexed citations
14.
Babicki, Mateusz, Damian Kołat, Żaneta Kałuzińska‐Kołat, et al.. (2023). Prevalence and assessment of risk factors among Polish adults with post-COVID syndrome: 12-month follow-up study. Polskie Archiwum Medycyny Wewnętrznej. 133(12). 8 indexed citations
15.
Banach, Maciej & Stanisław Surma. (2023). A Look to the Past - What Has Had the Biggest Impact on Lipids in the Last Four Decades? A Personal Perspective. Archives of Medical Science. 19(3). 559–564. 12 indexed citations
16.
Ganjali, Shiva, Maryam Matbou Riahi, Khadijeh Mahboobnia, et al.. (2023). An in vitro investigation of the effects of Urolithins A and B on low-density lipoprotein uptake and its regulatory genes. European Heart Journal. 44(Supplement_2). 2 indexed citations
17.
Mahmoudi, Ali, Alexandra E. Butler, Maciej Banach, Tannaz Jamialahmadi, & Amirhossein Sahebkar. (2023). Identification of Potent Small-Molecule PCSK9 Inhibitors Based on Quantitative Structure-Activity Relationship, Pharmacophore Modeling, and Molecular Docking Procedure. Current Problems in Cardiology. 48(6). 101660–101660. 5 indexed citations
18.
19.
Okechukwu, Chidiebere Emmanuel, Mark D. Griffiths, Mauro Giovanni Carta, et al.. (2022). Biological and practical considerations regarding circadian rhythm and mental health relationships among nurses working night shifts: a narrative review and recommendations. Rivista di psichiatria. 57(2). 67–79. 16 indexed citations
20.
Mariscalco, Giovanni, Catherine Klersy, Marco Zanobini, et al.. (2008). Atrial Fibrillation After Isolated Coronary Surgery Affects Late Survival. Circulation. 118(16). 1612–1618. 228 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erik S.G. Stroes Breakdown of academic impact, for papers by Winfried März Breakdown of academic impact, for papers by Alberico L. Catapano Breakdown of academic impact, for papers by Robert A. Hegele Breakdown of academic impact, for papers by Chris J. Packard Breakdown of academic impact, for papers by Ulrich Laufs Breakdown of academic impact, for papers by Michael H. Davidson Breakdown of academic impact, for papers by Ulf Landmesser Breakdown of academic impact, for papers by Robert H. Eckel Breakdown of academic impact, for papers by Henry N. Ginsberg
Rankless by CCL
2026